EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ho, E.
Right arrow Articles by Bray, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ho, E.
Right arrow Articles by Bray, T. M.
Experimental Biology and Medicine 226:103-111 (2001)
© 2001 Society for Experimental Biology and Medicine


ORIGINAL ARTICLE

Dietary Zinc Supplementation Inhibits NF {kappa}B Activation and Protects Against Chemically Induced Diabetes in CD1 Mice

Emily Ho*, Ning Quan{dagger}, Yu-Hwai Tsai*, Weimin Lai{dagger} and Tammy M. Bray*,1

* Department of Human Nutrition, and
{dagger} Department of Oral Biology, The Ohio State University, Columbus, Ohio 43210

Zinc status in patients with Type I diabetes is significantly lower than healthy controls. Whether zinc supplementation can prevent the onset of Type I diabetes is unknown. Recent studies have suggested that the generation of reactive oxygen species (ROS) is a cause of ß cell death leading to Type I diabetes. In addition, we found that activation of NF{kappa}B (a ROS-sensitive transcription factor that regulates immune responses) may be the key cellular process that bridges oxidative stress and the death of ß cells. Zinc is a known antioxidant in the immune system. Therefore, this study is designed to test whether an increase in dietary zinc can prevent the onset of Type I diabetes by blocking NF{kappa}B activation in the pancreas. The results show that high zinc intake significantly reduced the severity of Type I diabetes (based on hyperglycemia, insulin level, and islet morphology) in alloxan and streptozotocin-induced diabetic models. Zinc supplementation also inhibited NF{kappa}B activation and decreased the expression of inducible NO synthase, a downstream target gene of NF{kappa}B. It is concluded that zinc supplementation can significantly inhibit the development of Type I diabetes. The ability of zinc to modulate NF{kappa}B activation in the diabetogenic pathway may be the key mechanism for zinc's protective effect. Inhibition of the NF{kappa}B pathway may prove to be an important criterion for choosing nutritional strategies for Type I diabetes prevention.

Key Words: reactive oxygen species • free radicals • zinc • NF{kappa}B • diabetes • alloxan • streptozotocin




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
L. Uusitalo, M. G Kenward, S. M Virtanen, U. Uusitalo, J. Nevalainen, S. Niinisto, C. Kronberg-Kippila, M.-L. Ovaskainen, L. Marjamaki, O. Simell, et al.
Intake of antioxidant vitamins and trace elements during pregnancy and risk of advanced {beta} cell autoimmunity in the child
Am. J. Clinical Nutrition, August 1, 2008; 88(2): 458 - 464.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
X. Kang, Z. Song, C. J. McClain, Y. J. Kang, and Z. Zhou
Zinc Supplementation Enhances Hepatic Regeneration by Preserving Hepatocyte Nuclear Factor-4{alpha} in Mice Subjected to Long-Term Ethanol Administration
Am. J. Pathol., April 1, 2008; 172(4): 916 - 925.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
E. MOCCHEGIANI, R. GIACCONI, C. CIPRIANO, L. COSTARELLI, E. MUTI, S. TESEI, C. GIULI, R. PAPA, F. MARCELLINI, E. MARIANI, et al.
Zinc, Metallothioneins, and Longevity:: Effect of Zinc Supplementation: Zincage Study
Ann. N.Y. Acad. Sci., November 1, 2007; 1119(1): 129 - 146.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Z. Zhou, X. Kang, Y. Jiang, Z. Song, W. Feng, C. J. McClain, and Y. J. Kang
Preservation of Hepatocyte Nuclear Factor-4{alpha} Is Associated with Zinc Protection Against TNF-{alpha} Hepatotoxicity in Mice
Experimental Biology and Medicine, May 1, 2007; 232(5): 622 - 628.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
F. Chimienti, S. Devergnas, F. Pattou, F. Schuit, R. Garcia-Cuenca, B. Vandewalle, J. Kerr-Conte, L. Van Lommel, D. Grunwald, A. Favier, et al.
In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion
J. Cell Sci., October 15, 2006; 119(20): 4199 - 4206.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
P. Schott-Ohly, A. Lgssiar, H.-J. Partke, M. Hassan, N. Friesen, and H. Gleichmann
Prevention of Spontaneous and Experimentally Induced Diabetes in Mice With Zinc Sulfate-Enriched Drinking Water Is Associated with Activation and Reduction of NF-{kappa}B and AP-1 in Islets, Respectively
Experimental Biology and Medicine, December 1, 2004; 229(11): 1177 - 1185.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. M. Norris, K. Barriga, G. Klingensmith, M. Hoffman, G. S. Eisenbarth, H. A. Erlich, and M. Rewers
Timing of Initial Cereal Exposure in Infancy and Risk of Islet Autoimmunity
JAMA, October 1, 2003; 290(13): 1713 - 1720.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. D Tran, G. S Howarth, P. Coyle, J. C Philcox, A. M Rofe, and R. N Butler
Dietary supplementation with zinc and a growth factor extract derived from bovine cheese whey improves methotrexate-damaged rat intestine
Am. J. Clinical Nutrition, May 1, 2003; 77(5): 1296 - 1303.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Endocr. Rev., October 1, 2002; 23(5): 599 - 622.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Experimental Biology and Medicine.